Advertisement
Cigna-Express Scripts deal unlikely to benefit consumers

Cigna-Express Scripts deal unlikely to benefit consumers

By Alex Kacik and Shelby Livingston  |  March 12, 2018

The $67 billion merger would allow Cigna to lower its costs by insourcing PBM services, and absorb the profits of the biggest stand-alone PBM at a time when its competitors are also pairing up with providers of pharmacy services.

Cigna to buy Express Scripts in $67 billion deal

Cigna to buy Express Scripts in $67 billion deal

By Shelby Livingston  |  March 08, 2018

Supply chain experts are skeptical the $67 billion Cigna Corp.-Express Scripts deal will do much to transform the healthcare industry, let alone deliver any significant savings to customers.

Cigna CEO sees opportunity in Amazon's new venture

Cigna CEO sees opportunity in Amazon's new venture

By Shelby Livingston  |  February 01, 2018

Cigna Corp. CEO David Cordani said there's opportunity for the insurer in the Amazon-JPMorgan Chase-Berkshire Hathaway venture. Meanwhile, the insurer reported that customer growth and higher premiums and fees helped boost its 2017 revenue.

CMS lifts Medicare Advantage sanctions on Cigna

CMS lifts Medicare Advantage sanctions on Cigna

By Shelby Livingston  |  June 16, 2017

Bloomfield, Conn.-based Cigna may immediately resume marketing its Medicare Advantage plans and enrolling members. Insurance industry analysts noted that the lifted sanctions pave the way for Cigna to pursue an acquisition in the lucrative Medicare Advantage segment.

Anthem may look for last-ditch options after Cigna merger rejected

Anthem may look for last-ditch options after Cigna merger rejected

By Shelby Livingston  |  April 28, 2017

After convincing one appellate judge that the $54 billion proposed merger had merit, Anthem may continue its unlikely fight to defend the deal and separately avoid paying a $1.85 billion break-up fee and other damages to Cigna.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print